KFS
TXMD icon

KMS Financial Services’s TherapeuticsMD TXMD Stock Holding History

KMS Financial Services’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$97K Hold
420
– – 0.01% 519
2014
Q2 		$93K Buy
+420
New +$93.5K 0.01% 529

Other funds holding TXMD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KMS Financial Services's TXMD Position: Q3 2014 in Review

KMS Financial Services held its TherapeuticsMD (TXMD) position steady in Q3 2014 at 420 shares worth $97K. The position accounts for 0.01% of the portfolio, ranked #519.

KMS Financial Services first reported a position in TXMD in Q2 2014 and has held it in 2 quarters since. 82 funds tracked by Wall St. Rank hold TXMD as of Q3 2014.

  • KMS Financial Services held 420 shares of TherapeuticsMD worth $97K as of Q3 2014.
  • KMS Financial Services left its TherapeuticsMD share count unchanged in Q3 2014.
  • TherapeuticsMD made up 0.01% of KMS Financial Services's portfolio in Q3 2014, its #519 holding.
  • KMS Financial Services first reported a position in TherapeuticsMD in Q2 2014 and has held it in 2 quarters since.
  • 82 funds tracked by Wall St. Rank held TherapeuticsMD as of Q3 2014.

Based on KMS Financial Services's 13F filing for Q3 2014, filed 14 Nov 2014.